Legacy fraud detection can't keep up with modern schemes.
Health payers lose billions each year to pharmacy billing fraud. Rule-based claim-edit systems miss novel patterns, generate high false positive rates, and leave Special Investigations Units buried in unactionable alerts.
Opioid overprescribing
Diversion-driven day-supply patterns that exceed specialty and geographic norms.
Brand-over-generic bias
Prescribing inflated by manufacturer payments or kickback arrangements.
Collusion networks
Coordinated provider-pharmacy-beneficiary rings invisible to single-claim analytics.
Alert fatigue
SIU teams drowning in false positives from rigid rule engines — real fraud slips through.